Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.
- DOI
- 10.1177/20552173261478412
- Published
- 2026 Jul-Sep
- Container
- Multiple sclerosis journal - experimental, translational and clinical
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20552173261478412,
title = {Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.},
author = {McCormack B and Bacchetti A and Lin TY and Moretti GS and Filippatou A and Gakis G and O'Donnell MM and Lambert CM and Lee NJ and Ecoff K and Davis S and Otero-Duran G and Gulati A and Didouchevski A and Lievers E and Pellegrini N and Ezzedin O and Lambe J and Moussa H and Fitzgerald K and Newsome SD and Mowry EM and Sotirchos ES and Calabresi PA and Nourbakhsh B and Saidha S},
year = {2026},
journal = {Multiple sclerosis journal - experimental, translational and clinical},
doi = {10.1177/20552173261478412},
url = {https://doi.org/10.1177/20552173261478412}
}RIS
TY - JOUR TI - Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis. AU - McCormack B AU - Bacchetti A AU - Lin TY AU - Moretti GS AU - Filippatou A AU - Gakis G AU - O'Donnell MM AU - Lambert CM AU - Lee NJ AU - Ecoff K AU - Davis S AU - Otero-Duran G AU - Gulati A AU - Didouchevski A AU - Lievers E AU - Pellegrini N AU - Ezzedin O AU - Lambe J AU - Moussa H AU - Fitzgerald K AU - Newsome SD AU - Mowry EM AU - Sotirchos ES AU - Calabresi PA AU - Nourbakhsh B AU - Saidha S PY - 2026 JO - Multiple sclerosis journal - experimental, translational and clinical DO - 10.1177/20552173261478412 UR - https://doi.org/10.1177/20552173261478412 ER -
APA
B, M., A, B., TY, L., GS, M., A, F., G, G., MM, O., CM, L., NJ, L., K, E., S, D., G, O., A, G., A, D., E, L., N, P., O, E., J, L., H, M., K, F., SD, N., EM, M., ES, S., PA, C., B, N., & S, S. (2026). Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.. Multiple sclerosis journal - experimental, translational and clinical. https://doi.org/10.1177/20552173261478412